These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31324806)

  • 21. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics.
    Potter BM; Xie LH; Vuong C; Zhang J; Zhang P; Duan D; Luong TL; Bandara Herath HM; Dhammika Nanayakkara NP; Tekwani BL; Walker LA; Nolan CK; Sciotti RJ; Zottig VE; Smith PL; Paris RM; Read LT; Li Q; Pybus BS; Sousa JC; Reichard GA; Marcsisin SR
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2380-7. PubMed ID: 25645856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primaquine homodimers as potential antiplasmodial and anticancer agents.
    Pavić K; Rubinić B; Rajić Z; Fontinha D; Prudêncio M; Uzelac L; Kralj M; Held J; Zorc B
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126614. PubMed ID: 31431364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine.
    Pybus BS; Sousa JC; Jin X; Ferguson JA; Christian RE; Barnhart R; Vuong C; Sciotti RJ; Reichard GA; Kozar MP; Walker LA; Ohrt C; Melendez V
    Malar J; 2012 Aug; 11():259. PubMed ID: 22856549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.
    Portela MJ; Moreira R; Valente E; Constantino L; Iley J; Pinto J; Rosa R; Cravo P; do Rosário VE
    Pharm Res; 1999 Jun; 16(6):949-55. PubMed ID: 10397619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
    Awandu SS; Raman J; Makhanthisa TI; Kruger P; Frean J; Bousema T; Niemand J; Birkholtz LM
    Malar J; 2018 Mar; 17(1):120. PubMed ID: 29558929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum.
    Bray PG; Deed S; Fox E; Kalkanidis M; Mungthin M; Deady LW; Tilley L
    Biochem Pharmacol; 2005 Oct; 70(8):1158-66. PubMed ID: 16139253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art.
    Marcsisin SR; Reichard G; Pybus BS
    Pharmacol Ther; 2016 May; 161():1-10. PubMed ID: 27016470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.
    Daher A; Aljayyoussi G; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves JC; da Fonseca LB; da Silva DMD; Pinto DP; Rodrigues DF; Silvino ACR; de Sousa TN; de Brito CFA; Ter Kuile FO; Lalloo DG
    Malar J; 2019 Sep; 18(1):325. PubMed ID: 31547827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate.
    Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V; Babu PP
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1809-1829. PubMed ID: 29087218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.
    Pybus BS; Marcsisin SR; Jin X; Deye G; Sousa JC; Li Q; Caridha D; Zeng Q; Reichard GA; Ockenhouse C; Bennett J; Walker LA; Ohrt C; Melendez V
    Malar J; 2013 Jun; 12():212. PubMed ID: 23782898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia.
    Suputtamongkol Y; Chindarat S; Silpasakorn S; Chaikachonpatd S; Lim K; Chanthapakajee K; Kaewkaukul N; Thamlikitkul V
    Am J Trop Med Hyg; 2003 May; 68(5):620-3. PubMed ID: 12812357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
    Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
    Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-performance liquid chromatographic determination of dihydroorotate dehydrogenase of Plasmodium falciparum and effects of antimalarials on enzyme activity.
    Ittarat I; Webster HK; Yuthavong Y
    J Chromatogr; 1992 Nov; 582(1-2):57-64. PubMed ID: 1491058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A humanized mouse model for sequestration of Plasmodium falciparum sexual stages and in vivo evaluation of gametocytidal drugs.
    Duffier Y; Lorthiois A; Cisteró P; Dupuy F; Jouvion G; Fiette L; Mazier D; Mayor A; Lavazec C; Moreno Sabater A
    Sci Rep; 2016 Oct; 6():35025. PubMed ID: 27731362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor gametocytocidal activity of 45 mg primaquine in chloroquine-treated patients with acute, uncomplicated, Plasmodium falciparum malaria in Mumbai (Bombay): an issue of public-health importance.
    Gogtay NJ; Chogle AR; Sorabjee JS; Marathe SN; Kshirsagar NA
    Ann Trop Med Parasitol; 1999 Dec; 93(8):813-6. PubMed ID: 10715674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
    Baird JK; Louisa M; Noviyanti R; Ekawati L; Elyazar I; Subekti D; Chand K; Gayatri A; Instiaty ; Soebianto S; Crenna-Darusallam C; Djoko D; Hasto BD; Meriyenes D; Wesche D; Nelwan EJ; Sutanto I; Sudoyo H; Setiabudy R
    JAMA Netw Open; 2018 Aug; 1(4):e181449. PubMed ID: 30646129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs.
    Movellan J; Urbán P; Moles E; de la Fuente JM; Sierra T; Serrano JL; Fernàndez-Busquets X
    Biomaterials; 2014 Sep; 35(27):7940-50. PubMed ID: 24930847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmodium falciparum gametocytes: with a view to a kill.
    Butterworth AS; Skinner-Adams TS; Gardiner DL; Trenholme KR
    Parasitology; 2013 Dec; 140(14):1718-34. PubMed ID: 23953486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimalarial drug resistance: an increasing problem.
    Peters W
    Br Med Bull; 1982 May; 38(2):187-92. PubMed ID: 7052200
    [No Abstract]   [Full Text] [Related]  

  • 40. Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
    López-Antuñano FJ
    Salud Publica Mex; 1999; 41(5):410-9. PubMed ID: 11142837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.